help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, B.
Right arrow Articles by Feldman, E. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, B.
Right arrow Articles by Feldman, E. L.
Endocrinology Vol. 139, No. 12 4881-4889
Copyright © 1998 by The Endocrine Society

ARTICLES

Differential Regulation of Insulin Receptor Substrate-2 and Mitogen-Activated Protein Kinase Tyrosine Phosphorylation by Phosphatidylinositol 3-Kinase Inhibitors in SH-SY5Y Human Neuroblastoma Cells1

Bhumsoo Kim, Phillip S. Leventhal, Morris F. White and Eva L. Feldman

Neuroscience Program and Department of Neurology, University of Michigan (B.K., P.S.L., E.L.F.), Ann Arbor, Michigan 48109-0588; and Joslin Diabetes Center and Harvard Medical School (M.L.F.), Boston, Massachusetts 02215

Address all correspondence and requests for reprints to: Dr. Eva L. Feldman, Department of Neurology, University of Michigan, 4414 Kresge III, 200 Zina Pitcher Place, Ann Arbor, Michigan 48109-0588. E-mail: efeldman{at}umich.edu

Insulin-like growth factor I (IGF-I) is a potent neurotropic factor promoting the differentiation and survival of neuronal cells. SH-SY5Y human neuroblastoma cells are a well characterized in vitro model of nervous system growth. We report here that IGF-I stimulated the tyrosine phosphorylation of the type I IGF receptor (IGF-IR) and insulin receptor substrate-2 (IRS-2) in a time- and concentration-dependent manner. These cells lacked IRS-1. After being tyrosine phosphorylated, IRS-2 associated transiently with downstream signaling molecules, including phosphatidylinositol 3-kinase (PI 3-K) and Grb2. Treatment of the cells with PI 3-K inhibitors (wortmannin and LY294002) increased IGF-I-induced tyrosine phosphorylation of IRS-2. We also observed a concomitant increase in the mobility of IRS-2, suggesting that PI 3-K mediates or is required for IRS-2 serine/threonine phosphorylation, and that this phosphorylation inhibits IRS-2 tyrosine phosphorylation. Treatment with PI 3-K inhibitors induced an increased association of IRS-2 with Grb2, probably as a result of the increased IRS-2 tyrosine phosphorylation. However, even though the PI 3-K inhibitors enhanced the association of Grb2 with IRS-2, these compounds suppressed IGF-I-induced mitogen-activated protein kinase activation and neurite outgrowth. Together, these results indicate that although PI 3-K participates in a negative regulation of IRS-2 tyrosine phosphorylation, its activity is required for IGF-IR-mediated mitogen-activated protein kinase activation and neurite outgrowth.




This article has been cited by other articles:


Home page
 EndocrinologyHome page
A. M. Vincent, L. Perrone, K. A. Sullivan, C. Backus, A. M. Sastry, C. Lastoskie, and E. L. Feldman
Receptor for Advanced Glycation End Products Activation Injures Primary Sensory Neurons via Oxidative Stress
Endocrinology, February 1, 2007; 148(2): 548 - 558.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
D. Villa, M. Miloso, G. Nicolini, R. Rigolio, A. Villa, G. Cavaletti, and G. Tredici
Low-dose cisplatin protects human neuroblastoma SH-SY5Y cells from paclitaxel-induced apoptosis
Mol. Cancer Ther., September 1, 2005; 4(9): 1439 - 1447.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
H. Sun and R. Baserga
Deletion of the Pleckstrin and Phosphotyrosine Binding Domains of Insulin Receptor Substrate-2 Does Not Impair Its Ability to Regulate Cell Proliferation in Myeloid Cells
Endocrinology, November 1, 2004; 145(11): 5332 - 5343.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
V. C. Russo, S. Metaxas, K. Kobayashi, M. Harris, and G. A. Werther
Antiapoptotic Effects of Leptin in Human Neuroblastoma Cells
Endocrinology, September 1, 2004; 145(9): 4103 - 4112.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
L. M. Scavo, M. Karas, M. Murray, and D. Leroith
Insulin-Like Growth Factor-I Stimulates Both Cell Growth and Lipogenesis during Differentiation of Human Mesenchymal Stem Cells into Adipocytes
J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3543 - 3553.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
M. Prisco, A. Maiorana, C. Guerzoni, G. Calin, B. Calabretta, R. Voit, I. Grummt, and R. Baserga
Role of Pescadillo and Upstream Binding Factor in the Proliferation and Differentiation of Murine Myeloid Cells
Mol. Cell. Biol., June 15, 2004; 24(12): 5421 - 5433.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
B. Kim and E. L. Feldman
Insulin-like Growth Factor I Prevents Mannitol-induced Degradation of Focal Adhesion Kinase and Akt
J. Biol. Chem., July 19, 2002; 277(30): 27393 - 27400.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
L. Simpson, J. Li, D. Liaw, I. Hennessy, J. Oliner, F. Christians, and R. Parsons
PTEN Expression Causes Feedback Upregulation of Insulin Receptor Substrate 2
Mol. Cell. Biol., June 15, 2001; 21(12): 3947 - 3958.
[Abstract] [Full Text]

Home page
 Mol. Cell. Biol.Home page
A. M. Valverde, C. Mur, S. Pons, A. M. Alvarez, M. F. White, C. R. Kahn, and M. Benito
Association of Insulin Receptor Substrate 1 (IRS-1) Y895 with Grb-2 Mediates the Insulin Signaling Involved in IRS-1-Deficient Brown Adipocyte Mitogenesis
Mol. Cell. Biol., April 1, 2001; 21(7): 2269 - 2280.
[Abstract] [Full Text]

Home page
 DiabetesHome page
T. M. Pederson, D. L. Kramer, and C. M. Rondinone
Serine/Threonine Phosphorylation of IRS-1 Triggers Its Degradation: Possible Regulation by Tyrosine Phosphorylation
Diabetes, January 1, 2001; 50(1): 24 - 31.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
A. Morrione, G. Romano, M. Navarro, K. Reiss, B. Valentinis, M. Dews, E. Eves, M. R. Rosner, and R. Baserga
Insulin-like Growth Factor I Receptor Signaling in Differentiation of Neuronal H19-7 Cells
Cancer Res., April 1, 2000; 60(8): 2263 - 2272.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
A. Misawa, H. Hosoi, A. Arimoto, T. Shikata, S. Akioka, T. Matsumura, P. J. Houghton, and T. Sawada
N-Myc Induction Stimulated by Insulin-like Growth Factor I through Mitogen-activated Protein Kinase Signaling Pathway in Human Neuroblastoma Cells
Cancer Res., January 1, 2000; 60(1): 64 - 69.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
A. Nantel, M. Huber, and D. Y. Thomas
Localization of Endogenous Grb10 to the Mitochondria and Its Interaction with the Mitochondrial-associated Raf-1 Pool
J. Biol. Chem., December 10, 1999; 274(50): 35719 - 35724.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1998 by The Endocrine Society